Efficacy and Safety of Concomitant Proton Pump Inhibitor and Nivolumab in Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study.
暂无分享，去创建一个
B. Escudier | S. Oudard | G. Gravis | F. Joly | P. Barthélémy | S. Ladoire | A. Thiery-Vuillemin | C. Chevreau | L. Albiges | B. Laguerre | L. Derosa | L. Geoffrois | S. Négrier | C. Dalban | E. Rassy | F. Rolland | E. Colomba | C. Alves Costa Silva | M. Goupil | F. Tantot